Drugs & Targets European Commission approves Trecondi for hematopoietic stem cell transplantation June 28, 2019Vol.45 No.26
Drugs & Targets Intensity Therapeutics, Merck partner to evaluate INT230-6 and Keytruda June 28, 2019Vol.45 No.26
Drugs & Targets Development collaboration will focus on CAR-T cell therapy for breast cancer June 28, 2019Vol.45 No.26
Drugs & Targets FDA approves Amgen and Allergan’s Kanjinti, Herceptin biosimilar June 21, 2019Vol.45 No.25
Drugs & Targets Myriad receives second insurance reimbursement decision for its BRACAnalysis in Japan June 21, 2019Vol.45 No.25
